Introduction
Chorea is a hyperkinetic movement disorder characterised by excessive spontaneous movements that are irregularly timed, randomly distributed and abrupt. It ranges in severity from restlessness with mild, intermittent exaggeration of gesture and expression, fidgety movements of the hands (seen online video) and unstable dance-like gait to a continuous flowing of disabling and violent movements. In this article we discuss the causes of chorea and an approach to its assessment.
A brief history of chorea
The term chorea is from the Greek koreia () meaning a dance. The word was first used medically by the alchemist Paracelsus (1493-1541) to describe Chorea Sancti Viti (St Vitus' dance), which was probably an epidemic form of hysterical chorea occurring in the context of religious or superstitious fervour. 1 Thomas Sydenham (1624-1689), studying St
Vitus' dance, identified a form of childhood chorea that now bears his name.
One year after obtaining his medical qualification, George Huntington (1850-1916) in 1872 described a hereditary form of chorea "spoken of by those in whose veins the seeds of the disease are known to exist, with a kind of horror", with onset in adult life and associated with cognitive and psychiatric manifestations. Huntington's disease (HD) is the commonest hereditary cause of chorea, and the mutation causing it was identified in 1993 as a result of an international collaborative initiative.
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Differential diagnosis
The major causes of chorea can be simply divided into inherited and acquired (Table 1) . * the commonest cause of inherited chorea-the remainder of these disorders are rare.
Inherited causes

Huntington's disease
Huntington's disease (HD) is a progressive autosomal dominant neurodegenerative disorder and the commonest inherited cause of chorea. Onset is usually in adult life with a mean age of about 40 years, although juvenile and elderly onset are well described. It progresses inexorably, with death occurring 15-20 years from the time of onset. Prevalence is 4-10 per 100,000 in Western European populations, but HD has been described throughout the world.
Genetics and pathology
The gene defect associated with HD is a CAG repeat expansion, encoding polyglutamine repeats within the huntingtin protein. 2 The CAG repeat ranges between 10 and 29 copies on normal chromosomes, and is expanded to a range of 36-121 on HD chromosomes. CAG repeats above 40 are fully penetrant, with a borderline range between 36 and 39 repeats associated with reduced penetrance. 3 CAG repeat lengths tend to increase down generations, particularly when transmitted through the paternal lineage. 4 This underlies the phenomenon of anticipation-the increasing severity of HD during intergenerational transmission. There is a correlation between CAG repeat size and age of onset-the larger the repeat, the earlier the disease onset. 5 Most individuals with greater than 50 repeats develop the disease before the age of 30. 6 However, CAG repeat length accounts for only 50-70% of variation of age of onset, and does not predict the clinical phenotype nor the severity of disease progression. 7 
Motor features
HD can produce a wide range of phenotypic presentations and the signs and symptoms change as it progresses. 8 The onset of HD is often difficult to discern clearly and many patients have psychiatric problems or cognitive symptoms prior to the appearance of any motor problems. The definitive diagnosis of HD is usually made when motor abnormalities are noted on examination. Minor motor abnormalities seen early in the disease are general restlessness, abnormal eye movements, hyperreflexia and fidgety movements of fingers, hands and toes during stress or when walking. Oculomotor abnormalities are a cardinal feature of the disease and often the earliest motor sign. Saccadic abnormalities are characteristic, including delayed initiation and slowing and inability to suppress glances at novel stimuli. As the disease progresses, blinking and head thrusting are seen during saccade initiation.
Later, impaired pursuit and gaze impersistence are seen. 9 Patients develop more obvious extrapyramidal signs; chorea is seen in 90% of adult-onset patients with varying degrees of dystonia, parkinsonism and bradykinesia. A key motor abnormality in HD is impairment of voluntary motor function with clumsiness, motor impersistence, disturbances in fine motor control and motor speed. Gait disturbance is common with impairment of postural reflexes making patients more prone to falling. Dysarthria and dysphagia are common.
Cognitive features
Cognitive abnormalities are a near-universal feature and present early in the course of HD but vary greatly in severity. Executive function is most impaired with poor planning and judgement, impulsive behaviour, disorganisation and difficulty coping with multiple tasks.
Many patients exhibit psychomotor slowing with apathy, lack of self-care and loss of initiative.
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Psychiatric features
Psychiatric symptoms are common, particularly depression and anxiety. 10 Irritability is also common and some patients become aggressive. Obsessions and compulsions can make life difficult for carers. Psychosis is well-recognised but rare. Suicide is much more common in HD in the general population. 11 Psychiatric symptoms should be actively managed with the same drugs used in standard psychiatric practice. 
Huntington's disease phenocopies
The combination of chorea, cognitive impairment, psychiatric abnormalities and an autosomal dominant family history was diagnostic of HD until the advent of diagnostic genetic testing. 1% of suspected HD cases test negative for the CAG expansion and are known as HD phenocopies. The major genetic HD phenocopy syndromes are listed in Table   2 . A diagnosis is made in only 2% of HD phenocopy patients. 
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Neuroacanthocytosis
Neuroacanthocytosis refers to a group of neurological disorders in which acanthocytes are seen on peripheral blood films. Chorea-acanthocytosis is a rare autosomal recessive disorder associated with mutations in CHAC. 20 It causes a progressive, adult-onset syndrome encompassing movement disorder, psychiatric and cognitive changes that may mimic HD (see Table 2 ). The movement disorder includes chorea, dystonia and tics.
Orofacial dystonia is characteristic, with tongue protrusion and biting of the tongue and lips. 34 Chorea is a rare feature of thyrotoxicosis. It relates directly to elevated thyroid hormone levels and usually resolves once the euthyroid state is restored. 35 Hemichorea is the movement disorder most commonly associated with AIDS, and can be the presenting feature. In one case series, 5/51 cases of acquired chorea were AIDS-associated. 25 Chorea in AIDS is usually due to a striatal toxoplasmic abscess. Rarer causes of chorea in AIDS include cryptococcus, progressive multifocal leukoencephalopathy, HIV encephalitis and drug treatment.
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Chorea gravidarum usually presents in the first trimester of pregnancy and is self-limiting. Previous rheumatic fever, anti-basal ganglia antibodies and antiphospholipid syndrome are risk factors. 37 Chorea is a rare feature of polycythaemia rubra vera, a myeloproliferativea disorder causing increased red cell mass that commonly produces neurological manifestations. 38 Chorea is not seen in secondary polycythaemia, suggesting that it relates to an underlying molecular abnormality. A detailed drug history may reveal possible causes of chorea (see Table 3 ) but may also be a confounding factor, for instance in a neuroleptic-treated patient whose psychiatric disturbance is due to HD. Establishing the exact sequence of symptoms and drug treatments is essential.
A cognitive history should be obtained from both the patient and a friend or carer.
Particular attention should be paid to the subtle features of frontal-subcortical dementia such as poor organisation and impaired concentration.
A psychiatric history may reveal depression, anxiety or irritability common to HD and its phenocopies.
Examination
A neurological and general medical examination is essential in the assessment of any patient with new symptoms. Figure 1 highlights key examination findings and Table 5 lists the associations of abnormal findings in the differential diagnosis of chorea.
The first priority is to confirm the presence of chorea. Chorea is usually seen in general observation before formal examination. It is often best noticed out of the corner of the eyefor instance, you may observe a fidgeting foot while the patient is speaking-and may be enhanced by distraction. The first movement abnormality in Huntington's disease is often subtle flicking of the fingertips while walking (see online video). Chorea should be distinguished from the list of related disorders in Table 4 . In most cases chorea is bilateral, and symmetrical. Hemichorea is usually due to vascular causes or contralateral basal ganglia lesions (including AIDS-associated chorea).
The presence of other movement disorders is of importance. Cerebellar ataxia is unusual in adult-onset HD and suggests an alternative diagnosis such as spinocerebellar ataxia, Friedreich's ataxia or choreo-acanthocytosis. Dystonia and parkinsonism are present in moderate/advanced HD, juvenile HD and the Westphal variant. Orolingual dystonia is relatively specific to chorea-acanthocytosis. Investigation of chorea should be directed to the most likely causes (Figure 2) . In acute or subacute onset chorea, the diagnosis is most likely to be made on the basis of blood tests and neuroimaging. In chronic or clearly familial cases, genetic testing may render extensive clinical testing unnecessary. In some cases, both approaches may need to be pursued simultaneously. Genetic testing of any patient should always be preceded by genetic counselling. 
Genetic testing and counselling
We suggest a structured, sequential approach to genetic testing based on clinical findings ( Figure 3) . The identification of a new genetic diagnosis has widespread ramifications for the patient and their family members. A positive diagnostic genetic test for HD in a person with no known family history immediately means that all their siblings and children are at 50% risk of the disease. Genetic testing for any disease has the potential to cause significant distress and should not be performed without detailed genetic counselling. Most clinicians are aware of the need for counselling of at-risk individuals for predictive testing, but the fact that a patient is symptomatic does not remove the need to provide detailed counselling, time for reflection and support during and after delivery of the result. There are internationally agreed guidelines for testing of at-risk individuals in HD, which is always performed in a specialist genetics setting. 40 We summarise guidelines for diagnostic genetic testing in Table 7 , to highlight that, when correctly conducted, the process of genetic counselling requires time, support and expertise that may not be available in the busy general neurology clinic. We therefore recommend if possible that genetic testing be performed through specialist neurogenetics services and supported by lay organisations. 
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Pharmacological management of chorea
Chorea may cause cosmetic embarrassment or disability, but many patients do not notice the severity of their chorea. Indeed, it is often relatives who request treatment. Anti-choreic medication should be used sparingly as no drug is particularly efficacious, and motor sideeffects may worsen functional disability. Treatment of underlying causes, cognitive and psychiatric features is more important than symptomatic management of chorea. For functionally disabling chorea, sulpiride, olanzapine and risperidone at low doses are useful.
Tetrabenazine is a good option, but may cause sedation and depression. 
